CY1115190T1 - Φαρμακοτεχνικες μορφες αερολυματων περιλαμβανοντας διενυδρη φουμαρικη φορμοτερολη, ενα προωθητικο, αιθανολη και προεραιτικως ενα στεροειδες, οπου η διενυδρη φουμαρικη φορμοτερολη εχει ενα περιεχομενο υδατος του 4,8-4.28% κατα βαρος - Google Patents
Φαρμακοτεχνικες μορφες αερολυματων περιλαμβανοντας διενυδρη φουμαρικη φορμοτερολη, ενα προωθητικο, αιθανολη και προεραιτικως ενα στεροειδες, οπου η διενυδρη φουμαρικη φορμοτερολη εχει ενα περιεχομενο υδατος του 4,8-4.28% κατα βαροςInfo
- Publication number
- CY1115190T1 CY1115190T1 CY20141100443T CY141100443T CY1115190T1 CY 1115190 T1 CY1115190 T1 CY 1115190T1 CY 20141100443 T CY20141100443 T CY 20141100443T CY 141100443 T CY141100443 T CY 141100443T CY 1115190 T1 CY1115190 T1 CY 1115190T1
- Authority
- CY
- Cyprus
- Prior art keywords
- formoterol fumarate
- fumarate dihydrate
- steroid
- propellant
- ethanol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/20—Valves specially adapted to medical respiratory devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Μια φαρμακευτική φαρμακοτεχνική μορφή αερολύματος περιλαμβάνοντας δι-ένυδρη φουμαρική φορμοτερόλη σε εναιώρημα, και ένα στεροειδές σε εναιώρημα, και ένα προωθητικό, αιθανόλη, και προαιρετικώς ένα επιφανειοδραστικό, όπου η δι-ένυδρη φουμαρική φορμοτερόλη έχει ένα περιεχόμενο ύδατος περίπου του 4.8 έως 4.28% κατά βάρος.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0323684.1A GB0323684D0 (en) | 2003-10-09 | 2003-10-09 | Improvements in or relating to organic compounds |
EP04769711.5A EP1670432B1 (en) | 2003-10-09 | 2004-10-08 | Aerosol formulations comprising formoterol fumarate dihydrate, a propellant, ethanol and optionally a steroid, where the formoterol fumarate dihydrate has a water content of 4.8-4.28% by weight. |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115190T1 true CY1115190T1 (el) | 2017-01-04 |
Family
ID=29433594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100443T CY1115190T1 (el) | 2003-10-09 | 2014-06-18 | Φαρμακοτεχνικες μορφες αερολυματων περιλαμβανοντας διενυδρη φουμαρικη φορμοτερολη, ενα προωθητικο, αιθανολη και προεραιτικως ενα στεροειδες, οπου η διενυδρη φουμαρικη φορμοτερολη εχει ενα περιεχομενο υδατος του 4,8-4.28% κατα βαρος |
Country Status (12)
Country | Link |
---|---|
US (3) | US20070256685A1 (el) |
EP (1) | EP1670432B1 (el) |
CA (1) | CA2540038C (el) |
CY (1) | CY1115190T1 (el) |
DK (1) | DK1670432T3 (el) |
ES (1) | ES2472268T3 (el) |
GB (1) | GB0323684D0 (el) |
HU (1) | HUS2000052I1 (el) |
PL (1) | PL1670432T3 (el) |
PT (1) | PT1670432E (el) |
SI (1) | SI1670432T1 (el) |
WO (1) | WO2005034911A1 (el) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070212422A1 (en) * | 1999-11-10 | 2007-09-13 | Manfred Keller | Dry powder for inhalation |
SK286394B6 (sk) * | 2001-03-30 | 2008-09-05 | Jagotec Ag | Lekárske aerosólové prípravky |
GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
US8435497B2 (en) | 2003-06-13 | 2013-05-07 | Takeda Gmbh | Formoterol of and ciclesonide combination |
GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
GB0323685D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
PL1682537T3 (pl) | 2003-11-05 | 2012-09-28 | Sarcode Bioscience Inc | Modulatory adhezji komórkowej |
GB0602897D0 (en) * | 2006-02-13 | 2006-03-22 | Jagotec Ag | Improvements In Or Relating To Dry Powder Inhaler Devices |
GB0622818D0 (en) * | 2006-11-15 | 2006-12-27 | Jagotec Ag | Improvements in or relating to organic compounds |
GB0625303D0 (en) * | 2006-12-19 | 2007-01-24 | Jagotec Ag | Improvements in and relating to metered dose inhalers |
EP3797775A1 (en) | 2007-10-19 | 2021-03-31 | Novartis AG | Compositions and methods for treatment of diabetic retinopathy |
JP2011518155A (ja) * | 2008-04-15 | 2011-06-23 | サーコード コーポレイション | 免疫関連障害の局所治療に使用するためのエアゾール化lfa−1アンタゴニスト |
GB0918149D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
GB0918150D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved formulations |
GB201108039D0 (en) * | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
GB201117621D0 (en) * | 2011-10-12 | 2011-11-23 | Mexichem Amanco Holding Sa | Compositions |
GB201117619D0 (en) | 2011-10-12 | 2011-11-23 | Mexichem Amanco Holding Sa | Compositions |
GB201306984D0 (en) | 2013-04-17 | 2013-05-29 | Mexichem Amanco Holding Sa | Composition |
CA3007050C (en) | 2015-12-04 | 2020-12-08 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition comprising a formoterol compound |
GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
AU2017328910B2 (en) | 2016-09-19 | 2020-04-09 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
ES2968453T3 (es) | 2016-09-19 | 2024-05-09 | Mexichem Fluor Sa De Cv | Composición farmacéutica que comprende glicopirrolato |
CN113288869A (zh) | 2016-09-19 | 2021-08-24 | 墨西哥氟石股份公司 | 药物组合物 |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2503962A1 (de) | 1975-01-31 | 1976-08-05 | Thomae Gmbh Dr K | Spruehbare mittel in suspensionsform zur anwendung auf der haut |
JPS5529524A (en) | 1978-08-21 | 1980-03-01 | Toyo Aerosol Kogyo Kk | Powdery aerosol composition |
DE2914181C2 (de) * | 1979-04-07 | 1982-06-16 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Verfahren und Vorrichtung zum Trocknen temperaturempfindlicher Güter der Pharma- und Nahrungsmittelindustrie |
JPH01166505A (ja) | 1987-12-22 | 1989-06-30 | Teikoku Tsushin Kogyo Kk | 電子部品の筺体及びその製造方法 |
FR2666962B1 (fr) | 1990-09-26 | 1996-06-14 | Oreal | Composition antifongique sous forme de spray sec. |
SE9101090D0 (sv) | 1991-04-11 | 1991-04-11 | Astra Ab | Process for conditioning of water-soluble substances |
SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
JPH06135815A (ja) | 1992-10-30 | 1994-05-17 | Shiseido Co Ltd | 経皮吸収抑制組成物 |
DE4321288A1 (de) | 1993-06-26 | 1995-01-05 | Solvay Fluor & Derivate | Zusammensetzungen mit chlorfreien, gegebenenfalls wasserstoffhaltigen Fluorkohlenwasserstoffen |
EP0731688B1 (en) | 1993-12-02 | 2003-03-05 | Abbott Laboratories | Aerosol drug formulations for use with non-cfc propellants |
JP3707107B2 (ja) | 1995-09-18 | 2005-10-19 | 鈴木油脂工業株式会社 | 薬剤分散液及びその製造方法 |
US6054488A (en) * | 1996-06-11 | 2000-04-25 | 3M Innovative Properties Company | Medicinal aerosol formulations of formoterol |
US6361938B1 (en) | 1996-11-08 | 2002-03-26 | Elan Corporation, Plc | Peptides which enhance transport across tissues and methods of identifying and using the same |
CA2279648C (en) | 1997-01-30 | 2007-04-24 | Alpenstock Holdings Limited | Haemostatic aerosol composition |
WO1998034595A1 (de) * | 1997-02-05 | 1998-08-13 | Jago Research Ag | Medizinische aerosolformulierungen |
US6033548A (en) * | 1997-07-28 | 2000-03-07 | Micron Technology, Inc. | Rotating system and method for electrodepositing materials on semiconductor wafers |
US6086376A (en) | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
US6451285B2 (en) * | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
JP4570251B2 (ja) | 1998-07-24 | 2010-10-27 | ヤゴテック アーゲー | 医薬用エーロゾル製剤 |
ATE234604T1 (de) | 1998-08-04 | 2003-04-15 | Jago Res Ag | Medizinische aerosolformulierungen |
US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
CA2347856C (en) | 1998-11-13 | 2009-02-17 | Jago Research Ag | Dry powder for inhalation |
US6926911B1 (en) | 1998-12-22 | 2005-08-09 | The University Of North Carolina At Chapel Hill | Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
WO2000047203A1 (en) | 1999-02-12 | 2000-08-17 | Mqs, Inc. | Formulation and system for intra-oral delivery of pharmaceutical agents |
GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
GB0012260D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
GB0012261D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
US20060257324A1 (en) | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
BR0015884A (pt) | 2000-05-22 | 2003-07-08 | Chiesi Farma Spa | Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados |
AU2001247123A1 (en) | 2000-07-19 | 2002-02-05 | Aeropharm Technology, Inc. | A medicinal aerosol formulation |
WO2002011711A2 (en) | 2000-08-04 | 2002-02-14 | Longwood Pharmaceutical Research, Inc. | Formulations of mometasone and a bronchodilator for pulmonary administration |
HUP0302311A3 (en) | 2000-10-09 | 2006-07-28 | 3M Innovative Properties Co | Medicinal aerosol formulations |
SK286394B6 (sk) * | 2001-03-30 | 2008-09-05 | Jagotec Ag | Lekárske aerosólové prípravky |
US6455028B1 (en) * | 2001-04-23 | 2002-09-24 | Pharmascience | Ipratropium formulation for pulmonary inhalation |
AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
MEP30108A (en) * | 2002-03-01 | 2010-06-10 | Chiesi Farmaceutici S P | Formoterol superfine formulation |
GB0207899D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
US7582284B2 (en) * | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
EP1531866A1 (en) | 2002-08-29 | 2005-05-25 | Cipla Ltd. | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
WO2005004927A2 (en) | 2003-07-12 | 2005-01-20 | Jong-Hun Han | An aromatic emitting apparatus for using cigarjack |
WO2005027878A1 (en) | 2003-09-19 | 2005-03-31 | Penwest Pharmaceuticals Co. | Delayed released dosage forms |
GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
GB0323685D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
GB0918150D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved formulations |
JP6135815B1 (ja) | 2016-09-29 | 2017-05-31 | 東洋インキScホールディングス株式会社 | プリント配線板および電子機器 |
-
2003
- 2003-10-09 GB GBGB0323684.1A patent/GB0323684D0/en not_active Ceased
-
2004
- 2004-10-08 SI SI200432162T patent/SI1670432T1/sl unknown
- 2004-10-08 PT PT47697115T patent/PT1670432E/pt unknown
- 2004-10-08 DK DK04769711.5T patent/DK1670432T3/da active
- 2004-10-08 ES ES04769711.5T patent/ES2472268T3/es active Active
- 2004-10-08 PL PL04769711T patent/PL1670432T3/pl unknown
- 2004-10-08 WO PCT/IB2004/003481 patent/WO2005034911A1/en active Application Filing
- 2004-10-08 CA CA2540038A patent/CA2540038C/en active Active
- 2004-10-08 US US10/574,334 patent/US20070256685A1/en not_active Abandoned
- 2004-10-08 EP EP04769711.5A patent/EP1670432B1/en active Active
-
2013
- 2013-08-23 US US13/974,570 patent/US20140004052A1/en not_active Abandoned
-
2014
- 2014-06-18 CY CY20141100443T patent/CY1115190T1/el unknown
-
2015
- 2015-11-30 US US14/953,883 patent/US9895327B2/en active Active
-
2020
- 2020-12-07 HU HUS2000052C patent/HUS2000052I1/hu unknown
Also Published As
Publication number | Publication date |
---|---|
GB0323684D0 (en) | 2003-11-12 |
US20140004052A1 (en) | 2014-01-02 |
CA2540038A1 (en) | 2005-04-21 |
PT1670432E (pt) | 2014-06-23 |
US20160310452A1 (en) | 2016-10-27 |
US20070256685A1 (en) | 2007-11-08 |
HUS2000052I1 (hu) | 2020-12-28 |
EP1670432A1 (en) | 2006-06-21 |
CA2540038C (en) | 2014-08-12 |
DK1670432T3 (da) | 2014-06-10 |
PL1670432T3 (pl) | 2014-08-29 |
US9895327B2 (en) | 2018-02-20 |
EP1670432B1 (en) | 2014-03-19 |
WO2005034911A1 (en) | 2005-04-21 |
ES2472268T3 (es) | 2014-06-30 |
SI1670432T1 (sl) | 2014-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1115190T1 (el) | Φαρμακοτεχνικες μορφες αερολυματων περιλαμβανοντας διενυδρη φουμαρικη φορμοτερολη, ενα προωθητικο, αιθανολη και προεραιτικως ενα στεροειδες, οπου η διενυδρη φουμαρικη φορμοτερολη εχει ενα περιεχομενο υδατος του 4,8-4.28% κατα βαρος | |
ATE275393T1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
CL2008002407A1 (es) | Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04). | |
ATE445389T1 (de) | Liposomale glucocorticoide | |
CY1108137T1 (el) | Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα | |
PL410219A1 (pl) | Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca | |
CY1113267T1 (el) | Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1 | |
NO20080002L (no) | Formuleringer av konjugerte ostrogener og bazedoxifen | |
CY1109212T1 (el) | Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα | |
CY1111458T1 (el) | Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης | |
UY27720A1 (es) | Aroilpiridinonas monocíclicas, | |
CY1106774T1 (el) | Συνθεσεις φαρμακευτικων μεσων με βαση αλατα του τιοτροπιου και αλατα της σαλμετερολης | |
CR10732A (es) | Uso de valerato de estradiol o 17 b- estradiol en combinacion con dienogest en una terapia oral para mantener y / o incrementar la libido femenina | |
PA8625001A1 (es) | Composiciones de pelicula | |
TW200630213A (en) | Cement-based hydraulic flexible composites and package therefor | |
CY1112981T1 (el) | Μεθοδος και συνθεση για την αγωγη της ρινιτιδας | |
ECSP088287A (es) | Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asma | |
CY1108711T1 (el) | Συνθεσεις βενζοθειαζολιου και η χρηση αυτων | |
CR10690A (es) | Nuevos derivados de fluoreno, composiciones que los contienen y utilizacion como inhibidores de la proteina chaperona hsp90 | |
ITMI20020814A0 (it) | Nuovi analoghi delle strobilurine e loro uso quali acaricidi e insetticidi | |
ATE353231T1 (de) | Pharmazeutische zusammensetzungen | |
CL2004001317A1 (es) | Composicion farmaceutica que comprende el antagonista de receptores de progesterona 11b-(4-acetilfenil)-17b-hidroxi-17 alfa-(1,1,2,2,2-pentafluoroetil)-estra-4,9-dien-3-ona y un antiestrogeno puro; y su uso para tratar una enfermedad dependiente de h | |
DE60325420D1 (de) | Zahnputzformulierung in aerosolform | |
NL1022442C2 (nl) | Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen. | |
NO20060743L (no) | Nasal farmasoytisk sammensetning av piribedil |